We have shown that TMB and other genomic instability measures are not associated with the magnitude of the immune response in hereditary BRCA1/2 related breast and ovarian cancers, as well as in sporadic TNBC and sporadic HGSOC. This evidence concerns the gene BRCA1 and ovarian carcinoma.